.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Moodys
Chinese Patent Office
Healthtrust
Chubb
Farmers Insurance
Deloitte
US Department of Justice
McKinsey
US Army

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Use of an anti-Ang2 antibody
Abstract: A method of preventing or treating cancer using an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes to a Tie2 receptor while bound with Ang2.
Inventor(s): Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR)
Application Number:14/446,199
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-25► Subscribe SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR) ► SubscribeRXOrphansearch
Imclone
ERBITUX
cetuximab
VIAL; INTRAVENOUS1250840012004-06-18► Subscribe SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR) ► SubscribeRXOrphansearch
Genentech
AVASTIN
bevacizumab
VIAL; INTRAVENOUS1250850012004-02-26► Subscribe SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR) ► SubscribeRXsearch
Genentech
AVASTIN
bevacizumab
VIAL; INTRAVENOUS1250850022004-02-26► Subscribe SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
South Korea10-2013-0112089Sep 17, 2013

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
European Patent Office2848631Mar 18, 2015
South Korea20150032075Mar 25, 2015
United States of America2015079112Mar 19, 2015
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Federal Trade Commission
Johnson and Johnson
Colorcon
Cantor Fitzgerald
Julphar
Fish and Richardson
Harvard Business School
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot